UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000028372
Receipt number R000032226
Scientific Title Safety and feasibility of laparoscopic gastrectomy for resectable advanced gastric cancer
Date of disclosure of the study information 2017/08/01
Last modified on 2019/07/27 12:01:46

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Safety and feasibility of laparoscopic gastrectomy for resectable advanced gastric cancer

Acronym

Safety and feasibility of laparoscopic gastrectomy for resectable advanced gastric cancer

Scientific Title

Safety and feasibility of laparoscopic gastrectomy for resectable advanced gastric cancer

Scientific Title:Acronym

Safety and feasibility of laparoscopic gastrectomy for resectable advanced gastric cancer

Region

Japan


Condition

Condition

Advanced gastric cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the safety and feasibility of laparoscopic gastrectomy for resectable advanced gastric cancer

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Phase II


Assessment

Primary outcomes

Incidence of surgical complications greater than Grade III (Clavien-Dindo classification)

Key secondary outcomes

Proportion of conversion to open surgery, Incidence of adverse events, overall survival, recurrence-free survival


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Laparoscopic gastrectomy

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Histologically diagnosed gastric adenocarcionoma
2) cStage I, II or III disease curably treated with total, proximal, or distal gastrectomy with lymph node dissection
3) Eastern Cooperative Oncology Group (ECOG) PS of 0-1
4) Age over 18
5) Informed consent is obtained

Key exclusion criteria

1) Patients with psychiatric or mental disorders
2) Possibly pregnant, or breast feeding woman
3) Paticents with acute myocardial infaction in 6 months or with unstable ungina
4) Patients with pulmonary disease and require continuous oxygen therapy

Target sample size

75


Research contact person

Name of lead principal investigator

1st name Hiroya
Middle name
Last name Takeuchi

Organization

Hamamatsu University School of Medicine

Division name

Department of Surgery

Zip code

4313192

Address

1-20-1 Handayama, Higashi-ku, Hamamatsu, JAPAN

TEL

053-435-2279

Email

takeuchi@hama-med.ac.jp


Public contact

Name of contact person

1st name Yoshihiro
Middle name
Last name Hiramatsu

Organization

Hamamatsu University School of Medicine

Division name

Department of Surgery

Zip code

4313192

Address

1-20-1 Handayama, Higashi-ku, Hamamatsu, JAPAN

TEL

053-435-2279

Homepage URL


Email

hiramatu@hama-med.ac.jp


Sponsor or person

Institute

Hamamatsu University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Hamamatsu University School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee of Hamamatsu University School of Medicine (EC HUSM)

Address

1-20-1 Handayama, Higashi-ku, Hamamatsu, JAPAN

Tel

053-435-2680

Email

rinri@hama-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2017 Year 06 Month 23 Day

Date of IRB

2017 Year 06 Month 16 Day

Anticipated trial start date

2017 Year 08 Month 01 Day

Last follow-up date

2027 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 07 Month 25 Day

Last modified on

2019 Year 07 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032226


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name